Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 192.07M | 94.4% | $ 203.47M |
3/31/2025 | $ 189.96M | 94.34% | $ 201.35M |
12/31/2024 | $ 187.46M | 94.31% | $ 198.77M |
9/30/2024 | $ 178.67M | 93.62% | $ 190.86M |
6/30/2024 | $ 169.33M | 93.03% | $ 182.02M |
3/31/2024 | $ 164.14M | 92.42% | $ 177.6M |
12/31/2023 | $ 177.84M | 92.32% | $ 192.64M |
9/30/2023 | $ 194.28M | 91.7% | $ 211.85M |
6/30/2023 | $ 217.52M | 91.26% | $ 238.35M |
3/31/2023 | $ 233.3M | 90.89% | $ 256.69M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for VANDA PHARMACEUTICALS INC is calculated as follows: GP [ $ 218.27M ] / Revenues [ $ 241.44M ]
(=) Gross % [ 90.4% ]
Minimum
Jun 30, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.81K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.08% |
median | 49.46% |
std | 31.58% |